Biosimilars in the management of neutropenia: focus on filgrastim
Biosimilars in the management of neutropenia: focus on filgrastim
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Analyses the available evidence to be considered in order to design a strategy of use of granulocyte colony-stimulating factor (G-CSF) and biosimilars of filgrastim - the patent for which expired in Europe in 2006 and in the US in 2013 - to decrease morbidity and mortality related to infectious complications, and in particular neutropenia, in cance...
Alternative Titles
Full title
Biosimilars in the management of neutropenia: focus on filgrastim
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4762467
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4762467
Other Identifiers
ISSN
1177-5491,1177-5475
E-ISSN
1177-5491
DOI
10.2147/BTT.S73580
